SV Health Investors

SV Health Investors is a leading healthcare-focused venture capital firm with over 30 years of experience, specializing in biotechnology, medical devices, and healthcare services. Notable investments include companies like American Well, Nimbus Therapeutics, and Bicycle Therapeutics. Their portfolio spans groundbreaking areas such as precision medicine, dementia therapeutics, and digital health. The firm’s industry focus is deeply rooted in life sciences, with a particular emphasis on biotechnology, medtech, and healthcare growth opportunities. Their investments target startups across all stages, from early innovation to growth phases, with a sharp focus on transforming healthcare through innovative treatments. SV Health Investors operates globally, with key offices in Boston and London, primarily focusing on the US and UK markets. Their strategy revolves around creating value through a hands-on approach, often leading rounds and collaborating closely with entrepreneurs. They are known for their in-depth sector knowledge, especially in complex therapeutic areas, and provide capital along with operational expertise to help companies scale. The average check size varies by stage and sector, and SV is actively involved in both early-stage biotech ventures and more mature growth companies. The team is led by seasoned experts like Kate Bingham and Nikola Trbovic, combining extensive industry experience with a commitment to fostering diversity in their investments. Entrepreneurs seeking to approach SV should highlight strong scientific innovation and a clear path to clinical impact, as the fund prioritizes cutting-edge breakthroughs with high potential.